Nancy Pelosi calls Trump ‘morbidly obese’ and says it’s not a good idea for him to take hydroxychloroquine


dchoi@businessinsider.com (David Choi)
South Sudan vice president, wife test positive for coronavirus
Lives not lost: Asia sees unexpected gains in virus lockdowns
House Speaker Nancy Pelosi said on Monday that Donald Trump not to take a controversial drug because of his physical attributes, hours after the president claimed he was taking it daily for about 10 days.
“He’s our president and I would rather he not be taking something that has not been approved by the scientists, especially in his age group and his, shall we say, weight group,” Pelosi said during an interview with CNN host Anderson Cooper on Monday.
“I think it’s not a good idea,” she added.
Pelosi described Trump, who is 73 years old, as “morbidly obese” by citing his prior White House physicals that place him slightly above the Centers for Disease Control and Prevention’s requirements for being “obese.”
Standing at 6-feet 3-inches tall, Trump weighed in at 243 pounds in 2019 — four pounds greater than the previous year. His body mass index would place him at 30.4, slightly above the CDC’s guidelines for its overweight BMI range of 30.
During a press conference on Monday, Trump admitted to taking hydroxychloroquine, a malaria prophylactic drug, as a preventative measure to the coronavirus. Trump’s physician confirmed in a letter that Trump tested negative for the coronavirus, and that they were both concluded that “the potential benefit from treatment outweighed the relative risks.”
“I take it,” Trump told reporters. “I would’ve told you that three, four days ago, but we never had a chance because you never asked me the question.”
But scientists have not concluded whether hydroxychloroquine can be used to treat or prevent the coronavirus. The Food and Drug Administration warned against using the drug “outside of the hospital setting or a clinical trial due to risk of heart rhythm problems,” and could trigger other problems, including death.
Despite not being backed by health officials, Trump appeared to fully endorse the drug.
“Here’s my evidence: I get a lot of positive calls about it,” Trump said on Monday. “The only negative I’ve heard was the study where they gave it — was it the VA? — with people that aren’t big Trump fans.”
“But I get a lot of tremendously positive news on the hydroxy,” Trump added. “And I say … what do you have to lose?”
It is unclear if bodyweight is a contributing factor to complications with hydroxychloroquine.
Get Offers Like Never Before with COURTS Raya Sale
Step up your wealth with DBS Treasures
KUALA LUMPUR: The strict standard operating procedures (SOP) for open court hearings due to the Covid-19 coronavirus pandemic appears to have upset both the prosecution and the defence in the 1Malaysia Development Bhd (1MDB) trial, as the presiding judge in the case refused to relax the rules.
Britain and the United States on Tuesday urged Russia to stop sending mercenaries to the conflict in Libya, after a recent UN report confirmed the presence of Russian and Syrian fighters in the country. It confirms mercenaries from the Wagner Group are in Libya, and reveals the presence of Syrian fighters from Damascus supporting Marshal Khalifa Haftar.
MANFALUT, Egypt (AP) — On a hot Saturday afternoon, Mahrous Mahmoud is busy as can be. The professional soccer player, however, is working up a sweat in a different way these days — as a street vendor. At this time of the year, Mahmoud would be on the field playing as a defender for Beni Suef, a club in Egypt’s second division. But like millions in the Arab world’s most populous country, he has been hit hard by the coronavirus pandemic. These…
(ATTN: ADDS info in paras 3-7) SEOUL, May 19 (Yonhap) — A fire at a research center of LG Chem Ltd. killed one worker and injured two others Tuesday, firefighters said. The blaze occurred at the company’s catalyst lab in the central city of Seosan, some 120 kilometers south of Seoul, at around 2:20 p.m. Firefighters extinguished it at around 3:30 p.m. A 39-year-old researcher was killed and two workers, aged 47 and 27, respectively, suffered…